ST葫芦娃(605199.SH)：小儿肺热咳喘颗粒获得药物临床试验批准通知书

Core Viewpoint - ST HuLuWa (605199.SH) has received approval from the National Medical Products Administration for clinical trials of its pediatric lung heat cough and asthma granules, indicating a significant step in product development and potential market expansion [1] Company Summary - The clinical trial approval pertains to the improvement and development of the existing product "Pediatric Lung Heat Cough and Asthma Granules" (National Drug Approval Number Z20033152) [1] - The new formulation aims to enhance the original function by adding treatment for "lung heat syndrome caused by influenza" [1]